Log in

Leader of scheme that caused bank collapse set for release

Tuesday, June 30, 2020 | Associated Press

NORFOLK, Va. (AP) — The leader of a fraud scheme that precipitated the collapse of Bank of the Commonwealth nearly a decade ago will soon be released from federal prison amid concerns over the coronavirus pandemic, according to court documents.

Ed Woodard, the 77-year-old former bank president, has served less than a third of a 23-year sentence he received in November 2013 for multiple bank fraud and related charges, The Virginian-Pilot reported. Woodard was granted compassionate release last Friday by U.S. District Judge Raymond Jackson, who presided over the 10-week trial and sentencing.

Jackson wrote that Woodard’s age and many health problems — which include heart disease, diabetes and morbid obesity — leave him particularly vulnerable to the virus.

Before he can be released, Woodard must complete a two-week quarantine at Fort Dix, the federal prison in New Jersey where he’s been housed the past several years. Once out, he will be required to spend five years on home confinement.

In February 2019, after years of denying wrongdoing, Woodard confessed to perpetrating the fraud in the hopes of getting a new trial and possibly a shorter sentence. His strategy failed.

Last August, Woodard began asking for a compassionate release after he suffered a series of heart attacks. He later requested release due to the COVID-19 threat. The federal Bureau of Prisons denied them all, noting he hadn’t served at least half of his sentence as is typically required.

Prosecutors objected to his release in a 30-page court document, arguing that while there have been numerous positive coronavirus tests at the medium security camp at Fort Dix, there haven’t been any in the low-security area where Woodard is housed. The medium security section also hasn’t had any positive cases since May 6.

Two other bank officials were found guilty in the conspiracy, including Woodard’s son, Brandon.

6 Stocks to Help You Profit Off the Coronavirus PPE Boom

Every major global event brings with it changes to our national lexicon. Before the Covid-19 pandemic, few Americans knew what the initials PPE stood for. Today, virtually anyone knows that PPE stands for personal protective equipment.

At the onset of the mitigation policies, the goal of flattening the curve was being done to prevent our health care system from becoming overwhelmed. Part of that concern stemmed from a shortage of personal protective equipment. These are the masks, gloves, goggles and gowns that help protect medical workers against viral or bacterial infections.

As the novel coronavirus became labeled a global pandemic, the global mantra became to “flatten the curve” in an effort to prevent our healthcare system from being overwhelmed.

The United States is being referred to as being on a war time footing. Manufacturers that were already producing PPE have significantly ramped up capacity. And many companies are converting their excess manufacturing capacity to produce personal protective equipment.

In fairness, this may only be a reason for some of these companies to “keep the lights on” right now. But many of these companies have a good story to tell. And it’s that story that can make them solid investments in the future.

View the "6 Stocks to Help You Profit Off the Coronavirus PPE Boom".

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.